Dose distribution for a 32P-impregnated coronary stent:: Comparison of theoretical calculations and measurements with radiochromic film

被引:20
作者
Duggan, DM [1 ]
Coffey, CW [1 ]
Levit, S [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Ctr Radiat Oncol, Vanderbilt Clin B902, Nashville, TN 37232 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1998年 / 40卷 / 03期
关键词
intravascular brachytherapy; restenosis; P-32 beta dosimetry; stent;
D O I
10.1016/S0360-3016(97)00812-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Restenosis, caused by proliferation of smooth-muscle cells, limits the efficacy of catheter-based revascularization of coronary arteries, Irradiation has been shown to inhibit growth of smooth-muscle cells in vitro and to prevent restenosis in animal models following stent placement, An intraarterial source of P-32, a pure beta emitter with a half-life of 14.28 days and a 90% range in crater of 3.6 mm, is almost ideal for irradiating just arterial wall without exposing any other part of the patient's heart or any other organs, while posing minimal hazards to medical personnel, Two types of previously developed coronary stent impregnated,vith P-32 were investigated, This study aimed to calculate and measure the dose outside of two types of P-32-impregnated beta-emitting coronary stents under conditions closely simulating clinical use, Methods and Materials: The dose distributions in water surrounding these stents were calculated using a convolution method and measured by exposing radiochromic film in a solid-water phantom, Results: Experimental results were in excellent agreement with theoretical calculations. Conclusions: Radiochromic dosimetry can be used to measure the dose distribution around a beta-emitting intraarterial stent at distances as small as 0.1 mm from the stent surface, A simple cylindrical shell model is adequate for calculating the dose at points farther than 0.5 mm from the stent surface, (C) 1998 Elsevier Science Inc.
引用
收藏
页码:713 / 720
页数:8
相关论文
共 33 条
[1]   INTIMAL PROLIFERATION OF SMOOTH-MUSCLE CELLS AS AN EXPLANATION FOR RECURRENT CORONARY-ARTERY STENOSIS AFTER PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY [J].
AUSTIN, GE ;
RATLIFF, NB ;
HOLLMAN, J ;
TABEI, S ;
PHILLIPS, DF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (02) :369-375
[2]   THE PREVENTION OF HETEROTOPIC OSSIFICATION IN HIGH-RISK PATIENTS BY LOW-DOSE RADIATION-THERAPY AFTER TOTAL HIP-ARTHROPLASTY [J].
AYERS, DC ;
EVARTS, CM ;
PARKINSON, JR .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1986, 68A (09) :1423-1430
[3]   RABBIT EAR MODEL OF INJURY-INDUCED ARTERIAL SMOOTH-MUSCLE CELL-PROLIFERATION - KINETICS, REPRODUCIBILITY, AND IMPLICATIONS [J].
BANAI, S ;
SHOU, M ;
CORREA, R ;
JAKLITSCH, MT ;
DOUEK, PC ;
BONNER, RF ;
EPSTEIN, SE ;
UNGER, EF .
CIRCULATION RESEARCH, 1991, 69 (03) :748-756
[4]  
BERGER MJ, 1970, AEC S SERIES, V20, P63
[5]   ELECTRON DOSE REDUCTION COEFFICIENTS FOR 7 RADIONUCLIDES AND CYLINDRICAL GEOMETRY [J].
BROOKEMAN, VA ;
FITZGERALD, LT ;
MORIN, RL .
PHYSICS IN MEDICINE AND BIOLOGY, 1978, 23 (05) :852-864
[6]  
CALIFF RM, 1991, J AM COLL CARDIOL, V17, pB2
[7]   MORPHOLOGIC CHARACTERISTICS OF LESION FORMATION AND TIME-COURSE OF SMOOTH-MUSCLE CELL-PROLIFERATION IN A PORCINE PROLIFERATIVE RESTENOSIS MODEL [J].
CARTER, AJ ;
LAIRD, JR ;
FARB, A ;
KUFS, W ;
WORTHAM, DC ;
VIRMANI, R .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (05) :1398-1405
[8]   TREATMENT OF KELOIDS WITH EXCISION AND POSTOPERATIVE X-RAY-IRRADIATION [J].
ENHAMRE, A ;
HAMMAR, H .
DERMATOLOGICA, 1983, 167 (02) :90-93
[9]  
HANKE H, 1990, CIRC RES, V67, P6512
[10]   RESTENOSIS AFTER PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY (PTCA) - A REPORT FROM THE PTCA REGISTRY OF THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE [J].
HOLMES, DR ;
VLIETSTRA, RE ;
SMITH, HC ;
VETROVEC, GW ;
KENT, KM ;
COWLEY, MJ ;
FAXON, DP ;
GRUENTZIG, AR ;
KELSEY, SF ;
DETRE, KM ;
VANRADEN, MJ ;
MOCK, MB .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (12) :C77-C81